Abstract 2069: Initial PET imaging and pharmacokinetic results from a Phase I/II study of Zr-89-labeled anti-STEAP1 antibody in metastatic castrate-resistant prostate cancer (mCRPC) patients
Carrasquillo, Jorge A., Danila, Daniel C., Beylergil, Volkan, O'Donoghue, Joseph A., Cheal, Sarah M., Ruan, Shutian, Pandit-Taskar, Neeta, Fox, Josef J., Fleming, Stephen E., Zanzonico, Pat B., Ragupathi, Govind, Lyashchenko, Serge K., William, Simon P., Larson, Steven M., Scher, Howard I., Fine, Bernard M., Morris, Michael J.
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article